Foley partner Kyle Faget, co-chair of the Medical Devices & Equipment Area of Focus within the firm’s Health Care & Life Sciences Sector, is speaking on the panel “Exploring the Subtleties and Safe Zones of Off-Label Communications — Part 2” during the American Conference Institute’s FDA Boot Camp program on Thursday, March 26.
Medical and market access teams must inform without implying. This session delineates scientific exchange, health economics and outcomes research (HEOR), and payer communications so field conversations support care and the brand without drifting into misbranding.
Topics of discussion include:
- Differentiating scientific-exchange lanes and structuring medical-information responses.
- Deploying HEOR and safety communications and maintaining alignment with evidence.
- Anticipating attorney-general and plaintiff scrutiny and reducing litigation exposure.
Related Insights
March 4, 2026
Energy Current
FERC Reaffirms Strict Recertification Timing Requirement for QFs: Lessons for Transaction Teams
The Federal Energy Regulatory Commission recently reaffirmed a June 2025 decision requiring seven small power producers (the “Companies”)…
March 4, 2026
Health Care Law Today
Health Care Compliance in 2026: What Compliance Leaders Need to Know
PYA and Foley & Lardner hosted the 8th Annual “Let’s Talk Compliance” conference on January 22, 2026. Panelists included Foley attorneys…
March 4, 2026
Foley Viewpoints
Guyana’s Emergence as a Strategic Energy Powerhouse in a Volatile Global Oil Market
Over the past decade, Guyana has undergone one of the most dramatic economic and energy transformations in the world. Once among the poorest countries in the Western Hemisphere, Guyana is now rapidly establishing itself as a critical player in global oil markets—at a time when energy security, supply diversification, and geopolitical risk are at the forefront of policymaker and investor concerns.